Head and Neck Cancer Patients as a High-Risk Population for COVID-19

A medical correspondence paper discusses the vulnerability of head and neck cancer patients to severe COVID-19 outcomes. The text likely contains analysis and extrapolation from data on critically ill COVID-19 patients with and without cancer. It was authored by Flora Yan from the Medical University of South Carolina.

Use Cases

• Identify high-risk patient groups for severe COVID-19 based on immunosuppression and comorbidities mentioned in the description
• Analyze predictors of critical illness in COVID-19 patients based on factors like age, smoking, and cancer status discussed in the text
• Study the intersection of oncology and infectious disease outcomes based on the described patient population

Strengths

• Focuses on a specific, high-risk patient population (head and neck cancer patients)
• Cites specific COVID-19 statistics, such as a 5-8% critical illness rate and a 50% ICU mortality estimate

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Last update date is unknown; freshness unverified

Provenance

Source

Medical University of South Carolina, Department of Otolaryngology – Head and Neck Surgery

Collection Method

Medical correspondence paper, likely involving literature review and clinical extrapolation.

Time Range

Data and discussion relevant to the early COVID-19 pandemic period (late 2019 to April 2020).

Geography

Global context, with initial focus on Wuhan, China.